Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Karasek

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Endokrynologia Polska|June 30, 2017
Clinical and immunological changes in patients with active moderate-to-severe Graves' orbitopathy treated with very low-dose rituximabDavid Karasek, Lubica Cibickova, Marta Karhanova, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|April 9, 2011
Total adiponectin levels in dyslipidemic individuals: relationship to metabolic parameters and intima-media thicknessDavid Karasek, Helena Vaverkova, Milan Halenka, et al.
Frontiers in Endocrinology|July 6, 2026
Cardiovascular risk in inflammatory bowel disease: focus on lipids and visceral adipose tissueEva Karaskova, David Friedecky, David Kleparnik, et al.
International Journal of Molecular Sciences|April 30, 2021
Role of Adipose Tissue in Inflammatory Bowel DiseaseEva Karaskova, Maria Velganova-Veghova, Milos Geryk, et al.
Journal of Thrombosis and Thrombolysis|July 20, 2010
Prothrombotic markers in asymptomatic dyslipidemic subjectsDavid Karasek, Helena Vaverkova, Milan Halenka, et al.
Clinical Biochemistry|March 19, 2013
Positive association of adiponectin with soluble thrombomodulin, von Willebrand factor and soluble VCAM-1 in dyslipidemic subjectsHelena Vaverkova, David Karasek, Dalibor Novotny, et al.
Atherosclerosis|August 24, 2007
Positive association of adiponectin with soluble vascular cell adhesion molecule sVCAM-1 levels in patients with vascular disease or dyslipidemiaHelena Vaverkova, David Karasek, Dalibor Novotny, et al.
Journal of Cancer|November 29, 2019
Hypoglycemia as a Symptom of Neoplastic Disease, with a focus on Insulin-like Growth Factors Producing TumorsJan Schovanek, Lubica Cibickova, Filip Ctvrtlik, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|June 20, 2017
Pulse wave analysis and diabetes mellitus. A systematic reviewJaromira Gajdova, David Karasek, Dominika Goldmannova, et al.
Journal of Clinical Medicine|May 14, 2022
Adiponectin, A-FABP and FGF-19 Levels in Women with Early Diagnosed Gestational DiabetesDavid Karasek, Ondrej Krystynik, Veronika Kucerova, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Endokrynologia Polska|June 30, 2017
Clinical and immunological changes in patients with active moderate-to-severe Graves' orbitopathy treated with very low-dose rituximabDavid Karasek, Lubica Cibickova, Marta Karhanova, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|April 9, 2011
Total adiponectin levels in dyslipidemic individuals: relationship to metabolic parameters and intima-media thicknessDavid Karasek, Helena Vaverkova, Milan Halenka, et al.
Frontiers in Endocrinology|July 6, 2026
Cardiovascular risk in inflammatory bowel disease: focus on lipids and visceral adipose tissueEva Karaskova, David Friedecky, David Kleparnik, et al.
International Journal of Molecular Sciences|April 30, 2021
Role of Adipose Tissue in Inflammatory Bowel DiseaseEva Karaskova, Maria Velganova-Veghova, Milos Geryk, et al.
Journal of Thrombosis and Thrombolysis|July 20, 2010
Prothrombotic markers in asymptomatic dyslipidemic subjectsDavid Karasek, Helena Vaverkova, Milan Halenka, et al.
Clinical Biochemistry|March 19, 2013
Positive association of adiponectin with soluble thrombomodulin, von Willebrand factor and soluble VCAM-1 in dyslipidemic subjectsHelena Vaverkova, David Karasek, Dalibor Novotny, et al.
Atherosclerosis|August 24, 2007
Positive association of adiponectin with soluble vascular cell adhesion molecule sVCAM-1 levels in patients with vascular disease or dyslipidemiaHelena Vaverkova, David Karasek, Dalibor Novotny, et al.
Journal of Cancer|November 29, 2019
Hypoglycemia as a Symptom of Neoplastic Disease, with a focus on Insulin-like Growth Factors Producing TumorsJan Schovanek, Lubica Cibickova, Filip Ctvrtlik, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|June 20, 2017
Pulse wave analysis and diabetes mellitus. A systematic reviewJaromira Gajdova, David Karasek, Dominika Goldmannova, et al.
Journal of Clinical Medicine|May 14, 2022
Adiponectin, A-FABP and FGF-19 Levels in Women with Early Diagnosed Gestational DiabetesDavid Karasek, Ondrej Krystynik, Veronika Kucerova, et al.
Pageof 5